Parexel Biotech has entered into a strategic collaboration with Synairgen. The two companies are working together on a phase III study of SNG001, an inhaled treatment for patients hospitalized with COVID-19. The trial aims to enroll 900 patients across 20 countries. Yourway has 21 strategically located depots around the world, to help advance all trials, at any scale, everywhere.